Looking for the B2B SaaS growth agency? We are now over at Growigami.com
← All Stories
Regulatory

FVP Health Innovation Fund Files Under Section 3(c)(1)

D - FVP Health Innovation Fund, L.P. filed a notice under Section 3(c)(1) of the Investment Company Act on April 8, 2026, according to SEC EDGAR.

A woman in a white dress stands on a rocky beach, embracing the serene seascape at sunset.
Photo by Thiều Hoàng Phước on Pexels

FVP Health Innovation Fund Submits SEC Filing

D - FVP Health Innovation Fund, L.P., identified by CIK number 0002105384, filed a document on April 8, 2026, under Item 3C of the Investment Company Act, according to SEC EDGAR. The filing specifically references Item 3C.1, which pertains to Section 3(c)(1). This filing, with accession number 0002105384-26-000002, was submitted as a 9 KB document.

Details of the Filing

The entity D - FVP Health Innovation Fund, L.P. is the filer, and the document is archived under the provided SEC EDGAR link. Section 3(c)(1) is indicated in the filing, as stated in the source material. The filing date of April 8, 2026, aligns with the requirements for reporting under the Investment Company Act.

Regulatory Context

As widely known, filings under the Investment Company Act often involve exemptions for private funds; in this case, D - FVP Health Innovation Fund, L.P.’s filing cites Section 3(c)(1), according to SEC EDGAR. The document size of 9 KB reflects a standard notice format for such regulatory submissions.

Implications for Emerging Managers

D - FVP Health Innovation Fund, L.P.’s filing under Section 3(c)(1) on April 8, 2026, represents a routine regulatory step, as per the source. While Section 3(c)(1) exemptions are common in private fund contexts, this specific filing by the fund is documented in the SEC records, according to SEC EDGAR.

Sources
Get capital raising signals before they hit the news.
Join Waitlist